X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (62) 62
humans (61) 61
male (33) 33
female (32) 32
adult (30) 30
middle aged (30) 30
gastroenterology & hepatology (25) 25
hepacivirus - immunology (24) 24
hepatitis c - immunology (23) 23
microbiology (21) 21
peptides (20) 20
acute disease (18) 18
biochemistry (18) 18
hepacivirus - genetics (18) 18
beer (17) 17
chemistry (17) 17
compositions thereof (17) 17
culture media (17) 17
enzymology (17) 17
human necessities (17) 17
hygiene (17) 17
medical or veterinary science (17) 17
metallurgy (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
organic chemistry (17) 17
preparations for medical, dental, or toilet purposes (17) 17
propagating, preserving or maintaining microorganisms (17) 17
specific therapeutic activity of chemical compounds ormedicinal preparations (17) 17
spirits (17) 17
vinegar (17) 17
virology (17) 17
wine (17) 17
hepatitis c, chronic - immunology (16) 16
abridged index medicus (15) 15
cd4-positive t-lymphocytes - immunology (15) 15
health aspects (15) 15
immunology (15) 15
hepatitis (14) 14
infection (14) 14
aged (13) 13
hepatitis c (13) 13
hepatitis c virus (13) 13
lymphocytes (12) 12
infections (11) 11
t cells (11) 11
adolescent (10) 10
cd8-positive t-lymphocytes - immunology (10) 10
gastroenterology and hepatology (10) 10
liver (10) 10
t-lymphocytes - immunology (10) 10
activation (9) 9
cells, cultured (9) 9
cytokines (9) 9
epitopes (9) 9
hepatitis c - virology (9) 9
hepatitis c, chronic - virology (9) 9
infectious diseases (9) 9
virus-infection (9) 9
analysis (8) 8
antiviral agents - therapeutic use (8) 8
genotype (8) 8
hepatitis c - drug therapy (8) 8
interferon-alpha - therapeutic use (8) 8
investigating or analysing materials by determining theirchemical or physical properties (8) 8
lymphocyte activation (8) 8
measuring (8) 8
nonstructural protein-3 (8) 8
physics (8) 8
testing (8) 8
viral clearance (8) 8
antiviral agents (7) 7
cell proliferation (7) 7
hepatitis b (7) 7
interferon (7) 7
medizin (7) 7
mice (7) 7
research (7) 7
virus diseases (7) 7
viruses (7) 7
animals (6) 6
antigen (6) 6
antigens (6) 6
cells (6) 6
genetic aspects (6) 6
hepacivirus - isolation & purification (6) 6
hepatitis b, chronic - immunology (6) 6
interleukins - genetics (6) 6
medicine (6) 6
persistence (6) 6
studies (6) 6
viral load (6) 6
alleles (5) 5
antigenic determinants (5) 5
biology (5) 5
care and treatment (5) 5
crohn's disease (5) 5
expression (5) 5
gene expression (5) 5
hepatitis b - immunology (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


MMW-Fortschritte der Medizin, ISSN 1438-3276, 02/2019, Volume 161, Issue 3, pp. 61 - 63
Journal Article
MMW - Fortschritte der Medizin, ISSN 1438-3276, 2/2019, Volume 161, Issue 3, pp. 61 - 63
Die Hepatitis E galt lange als seltene Reisekrankheit. Tatsächlich ist die Infektion in Europa die häufigste Ursache einer akuten Virushepatitis. Übertragen... 
Hepatitis E | ribavirin | Medicine & Public Health | infectious disease | liver | General Practice / Family Medicine | Internal Medicine | zoonosis
Journal Article
MMW Fortschritte der Medizin, 02/2019, Volume 161, Issue 3, p. 61
Journal Article
Gut, ISSN 0017-5749, 10/2014, Volume 63, Issue 10, pp. 1532 - 1533
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 12, pp. e15200 - e15200
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 6, pp. 497 - 506
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2014, Volume 9, Issue 8, pp. e105703 - e105703
Background: T-cell exhaustion seems to play a critical role in CD8(+) T-cell dysfunction during chronic viral infections. However, up to now little is known... 
CD8(+) | ACTIVATION | VIRUS | MEMORY | MULTIDISCIPLINARY SCIENCES | EXPANSION | RESTORATION | INFECTION | RECEPTORS | HEPATITIS-C | EXHAUSTION | Hepatitis B, Chronic - immunology | Gene Expression Regulation - immunology | Humans | Middle Aged | Male | CD4-Positive T-Lymphocytes - pathology | CD4-Positive T-Lymphocytes - immunology | Adolescent | Adult | Female | Aged | Programmed Cell Death 1 Receptor - immunology | Costimulatory and Inhibitory T-Cell Receptors - immunology | Hepatitis B, Chronic - pathology | CD57 antigen | Cell proliferation | CC chemokine receptors | PD-1 protein | CD8 antigen | CD45RA antigen | Differentiation (biology) | Chronic infection | Cytotoxicity | Viruses | Lymphocytes T | Infections | Hepatitis | Receptors | CTLA-4 protein | Cell growth | Immunology | Interleukin 2 | Lymphocytes | Human immunodeficiency virus--HIV | Peripheral blood | Drb1 protein | Tumor necrosis factor-TNF | Hepatitis B virus | Antigens | Phenotypes | Immunological memory | Cytokines | Secretion | CCR7 protein | T cell receptors | Tumor necrosis factor-α | Cell differentiation | KLRG1 protein | CD4 antigen | Major histocompatibility complex | Tumor necrosis factor | Exhaustion | γ-Interferon | Influenza | PD-L1 protein | Viral infections | Hepatitis B | Apoptosis | Neutralization | Index Medicus | HIV | Human immunodeficiency virus
Journal Article
Hepatology, ISSN 0270-9139, 12/2010, Volume 52, Issue 6, pp. 1934 - 1947
Journal Article
Molecular Therapy, ISSN 1525-0016, 09/2013, Volume 21, Issue 9, pp. 1796 - 1805
Clearance of infections caused by the hepatitis C virus (HCV) correlates with HCV-specific T cell function. We therefore evaluated therapeutic vaccination in... 
VIRAL LOAD | MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | VIRUS-INFECTION | PROTEIN | ACUTE HCV INFECTION | CYTOTOXIC T-LYMPHOCYTES | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELLULAR IMMUNE-RESPONSES | GENETICS & HEREDITY | CHIMPANZEES | RHESUS MACAQUES | VACCINES | Recombinant Proteins - therapeutic use | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Middle Aged | Vaccines, DNA - immunology | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Polyethylene Glycols - adverse effects | Hepatitis C, Chronic - therapy | Male | RNA, Viral - blood | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Vaccines, DNA - administration & dosage | Viral Load | Interleukins - genetics | Ribavirin - administration & dosage | Adult | Female | Hepacivirus - physiology | Viral Hepatitis Vaccines - adverse effects | Standard of Care | Antiviral Agents - therapeutic use | Lymphocyte Activation | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Electroporation | Combined Modality Therapy | Vaccines, DNA - therapeutic use | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Recombinant Proteins - administration & dosage | Viral Hepatitis Vaccines - therapeutic use | Interferon-alpha - administration & dosage | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Vaccines, DNA - adverse effects | T-Lymphocytes - immunology | Interferon-alpha - adverse effects | Hepatitis C, Chronic - genetics | Index Medicus | Original
Journal Article